A strong immune response against transgenic cells is one markedly slowed the decline of reporter gene expression important limitation for long-term expression after adenoviand a positive effect was still detectable 200 days after ral gene transfer in mammals. Continuous pharmacological gene transfer. At the same time, antibody production was immunosuppression has been shown to ameliorate reduced by 50-60%. Continuous treatment with 15-DSG immune reactions and to prolong reporter gene expression.
Introduction
Since fiber or other proteins can hardly be removed from Recombinant adenoviruses are the most efficient in vivo the capsid, antigenicity can be circumvented to some gene transfer vehicles currently available. 1 One important extent by employment of recombinant viral vectors with target organ for the therapy of inherited diseases with fiber proteins of varying serotypes. 10 The second source adenoviral vectors is the liver due to its high efficacy of of antigenicity, the expression of viral genes, can be infection and a considerable liver tropism after systemic avoided by construction of recombinant viruses with application. 2 Two receptors have been found so far which extended deletions 6,11 and finally to the replacement of can mediate cellular uptake of the adenovirus, the first the entire viral genome. 12, 13 The contribution of these new one is an alpha-v-integrin receptor 3 and the so-called viral constructs for long-term expression has not been CAR-receptor (coxsackievirus and adenovirus receptor) reported so far. The third problem, which is important in which has recently been cloned. 4 The employment of gene therapy in general, the potential antigenicity of the recombinant adenoviruses for the transfer of therapeutic neoantigen, is difficult to assess and may be different for genes has one important limitation. Long-term gene versatile gene products. For these reasons, even in the soexpression is limited due to strong cellular and humoral called gutless adenoviral vectors of the latest generhost immune responses that inactivates or destroys transation, 14 immunogenicity will remain a problem and some genic cells and blocks repeated administration of viral kind of immunosuppression will become an unavoidable vectors by formation of neutralising antibodies.
5-7 There component of adenoviral gene transfer protocols. Several are three main sources of antigenicity in adenoviral vecstrategies have already been applied successfully to overtors which contribute to the strength and character of the come these problems. The constitutive expression of an immune response: viral proteins building the viral capimmunomodulatory gene (gp19) from the adenoviral E3 sid, 8 viral proteins persistently expressed from the vector 6 region has been shown to reduce the cytotoxic activity of and the transgene product itself. 9 Antifiber antibodies CD8 cells. 15, 16 Other genes with similar functions are the UL18 of the cytomegalovirus, ICP47 of herpes simplex virus or the EBNA1 of the Epstein-Barr virus. [17] [18] [19] They suppress the immune recognition and promote viral rep-processing and MHCI-mediated antigen presentation in wild-type infections. Another very effective way of preventing an adaptive immune response which could even lead to long-lasting tolerance induction in rodents is the functional inhibition of naive CD4 cells during antigen exposition with monoclonal antibodies. 15, 20, 21 Blocking the costimulatory CTLA4-B7.2 pathway with a monclonal antibody leads to similar results as the application of an anti-CD4 antibody. 22 Antibody formation is entirely preserved and long-lasting gene expression after adenoviral gene transfer has been shown in mouse models. 15, 20, 21 Pharmacological immunosuppression with the immunosuppressants cyclosporin A or FK506 has been shown to reduce immune response and prolongs reporter gene expression. 
Results
The repeated administration of 5 × 10 9 p.f.u. (Ad-hAAT) did not cause any measurable increase of gene Long-term expression of human alpha-1-antitrypsin expression. Blood samples were taken once before mice received 1 × 10 10 p.f.u. of Ad-hAAT vector and on days 5, 10, 20, Antibody formation against adenoviral proteins 30, 60, 100, 150, 200 and 220 after application and anaThe level of antibody formation directed against vector lysed for hAAT by an ELISA. Animals of all groups antigens was determined on day 30, 100, 150 and 200 showed a strong initial hAAT expression ranging from after virus application ( Figure 2 ). Continuous treatment 0.8 mg/ml to 3.2 mg/ml between individuals on day 5 ( Figure 1 ). Only minor differences could be observed between the groups on day 5 when peak expression was seen. Figure 1b shows the linear proportion of hAAT expression on day 30 to demonstrate especially the DSG effect. The observed differences between both DSG groups and the control group became significant from day 30. The decline of expression was not a continuous one but showed some kind of steps. The control group lost approximately 90% of expression between days 20 and 30. Human AAT levels in the FK506-treated and the CsA-treated groups dropped earlier than in the control group. In these two groups, a strong decline was notable showed gene expression comparable to the DSG group.
with DSG twice weekly for 150 days reduced the antipression of antibody development against antigens with a smaller molecular weight is somehow more efficient body formation by 80-90%. After DSG withdrawal on day 150, a slight induction was seen during the following than suppression of antigens with a higher weight (Figure 3 ). However, humoral response to penton base, 50 days. Compared with the control group immunosuppression with DSG for 5 days reduced antibody forpenton-associated and to fiber proteins could be detected in all mice of the DSG++ group. mation by about 50-60% during the whole course of 200 days. In the control group, antibody titers increased up to day 150, while titers in the FK506 and the CsA group Expression of bacterial ␤-galactosidase in mouse liver The highest expression of ␤-galactosidase (␤-gal) in livers peaked on day 30 and declined over the next 6 months.
To illustrate the difference in the antibody pattern of the control group was measured 6 days after application of 1 × 10 10 p.f.u. Ad-␤-gal. Expression dropped between the DSG++ and the control group, we probed a Western blot containing separated solubilized total adenover the next 2 weeks and reached almost background after 3 weeks (Figure 4) . After 6 weeks none of the control ovirus protein with serum of mice taken at day 150. Figure 3 shows the immunoblot along with the Commassieanimals showed any remaining ␤-galactosidase activity in the liver. The daily treatment with high doses of cyclostained viral extracts. Mice showed only a moderate response to the abundantly present hexon protein and sporin A (100 mg/kg/day) or 15-DSG (5 mg/kg/day) led to a sustained high level of ␤-galactosidase for the whole did not react significantly with any of the core proteins. Penton base, penton-associated and fiber protein seemed period of immunosuppression (21 days). Differences occurred in the rate of decline after withdrawal of to be strong antigens, despite being present in moderate amounts. Within the control group, differences were immunosuppression. ␤-Gal expression in all animals of the CsA group had returned back to baseline expression observed regarding the reactivity against individual antigens. The first mouse did not show any humoral on day 42, while all animals in the DSG group (DSG for 21 days) were still expressing approximately 10% of response to hexon protein, the second one did not respond to protein IX and the third mouse did not show maximum values. The group which received 15-DSG for 5 days only showed a slower decline of expression comany detectable response to the hexon-associated protein.
All animals in the DSG++ group responded to immunopared with the control group. On day 42, the members of this group still expressed about 3% of maximum values. suppression with a strong reduction of antibody development, at the same time all of them showed hAAT expression values between 10.5 and 15 g/ml. The antiDiscussion body pattern in the DSG++ group suggests that the supThis investigation suggests that a short treatment of mice with 15-deoxyspergualin has a long-standing positive effect on gene expression after adenoviral gene transfer while transient immunosuppression with FK506 and cyclosporin A leads to premature termination. These results were quite surprising since short-term immunosuppression with cyclosporin A and FK506 had been beneficial in several transplant models 28-30 and after adenoviral gene transfer in skeletal muscles. 23 It has been reported that even tolerance induction against the lymphocytic choriomeningitis virus in mice occurred after transient high-dose treatment with cyclosporin A. 31 We could clearly confirm a strong positive effect of high-dose cyclosporin A treatment on ␤-galactosidase expression as long as immunosuppression was continued, but after withdrawal expression declined rapidly. Both groups (15-DSG for 5 days and 21 days) showed a slower reduction rate of expression compared with the control and the CsA group. The different effects of 15-DSG compared with
Figure 3 Comparison of serum antibody pattern against adenoviral antigens of control and immunosuppressed animals 150 days after virus application. Electrophoresis of adenoviral proteins (12 g each lane) was performed on a 12% acrylamide gel, one lane (left) was directly stained with Coomassie-blue to visualize viral proteins. The other lanes were blotted and each lane was probed separately with sera of three mice of the control and the DSG++ group (15-DSG 5 mg/kg twice weekly for 150 days). The
Figure 4 32, 33 It seems to inhibit primarily the early induction phase rather than locus in the outbred strain NMRI. The long-lasting immunosuppressive effect of 15-DSG the effector phase of the cell-mediated lysis. 34 It inhibits lymphocyte proliferation in the mixed lymphocyte reacon the background of its affinity to heatshock proteins leads to a new and interesting theory about T lymphocyte tion, 33 kappa-light chain presentation in B cells and cytokine production in monocytes. 35 The molecular basis of activation which has recently been suggested by Matzinger et al. 37, 38 This theory says that activation of naive these diverse functions seems to be binding and inhibition of certain heat shock proteins and of the nuclear T lymphocytes during the first contact with an antigen requires some kind of alarm reaction. The model protranscription factor kappaB (NF-B) . 26 Since heat shock proteins are responsible for partial denaturation and poses the existence of mediators that are released or activated upon contact with antigen, assigning them a renaturation of proteins during their transport through membranes, their inactivation affects the transport of dangerous quality. These mediators are still hypothetical but heat shock proteins may be good candidates for this MHC molecules into the endoplasmatic reticulum and the Golgi apparatus.
function. Thus, 15-deoxyspergualin could serve as a rewarding tool for the investigation and understanding A second immunological function related to antigen processing and presentation is the denaturation of celluof immune functions and we have shown here that it can be an effective supplement for adenoviral gene therapy lar proteins or potential antigens before fragmentation at the proteasome and MHC-mediated presentation. In conprotocols. trast to 15-DSG, FK506 and cyclosporin A interfere with the expression of IL-2 in T lymphocytes which is required
Materials and methods
for self-activation and clonal proliferation. Both substances inhibit the dephosphorylation of transcription Preparation of recombinant adenovirus factors involved in IL-2 transcription. 36 Antigen fragmenRecombinant replication-deficient adenoviruses containtation and MHC-mediated presentation is one of the ing the cDNA of the human alpha-1-antitrypsin and the early steps in the adaptive immune response while ILbacterial ␤-galactosidase gene, both driven by an RSV 2 release and T lymphocyte activation is a downstream promoter, were provided by M Kay (Markey-Center, reaction. It has been shown that co-expression of viral University of Washington, Seattle, WA, USA). Both genes, which interfere with MHC I presentation, had a viruses were related to the adenovirus strain dl309 39 markedly positive effect on gene expression. 15 This obserwhich is still carrying a functional gp19 gene in E3. 15, 39 vation together with our findings suggest that an interViruses were propagated on human embryonic kidney vention in the early phase of antigen recognition is of cells (293 cells) and harvested 2 days after infection. Lysis greater relevance for long-term effects than blocking was performed in 0.1% NP40, 1 mm MgCl 2 , PBS and viral downstream effector functions like IL-2 release. The particles were purified by two rounds of cesium chloride observed rebound reaction could be mediated by a shift density gradient centrifugation. 40 Cesium chloride was from a primary TH2 to a TH1 response. In this particular removed by gel filtration on a Sephadex G-25 column case, we would expect a reduced humoral response in (Pharmacia, Uppsala, Sweden). Equilibration was perforthe FK506 and the cyclosporin group compared with the med with injection buffer containing 3 mm KCl, 1 mm control group. We could indeed observe a reduced MgCl 2 , PBS and sterile filtration was carried out through humoral response (Figure 2 ) in both groups, but the a 0.45 m filter (Schleicher and Schuell FP 030/2, Dassel, reduction could be related to the shorter expression of Germany). Virus suspension was supplemented with viral genes as well. There are only a few and contro-10% glycerol and stored in aliquots at −78°C. Titration versial reports as to possible rebound reactions after tranwas carried out in an endpoint dilution assay on 293 cells. sient immunosuppression with cyclosporin A or FK506.
15-DSG reduces antibody production even after shortterm treatment by about 50% despite an increased Animal procedures and immunosuppression Six-week-old female NMRI mice were purchased from reporter gene expression throughout the whole period of this trial. Permanent treatment (twice weekly 10 mg/kg) Bomholtgaard (Ry, Denmark). For investigation of hAAT long-term expression, five groups were set up, four mice reduces antibody production by on average 80-90%. A second virus dose given about 7 months after the first in each group. On day 0 each mouse received a dose of 1 × 10 10 p.f.u. in 200 l injection buffer (see above) via tail application did not lead to any measurable gene expression. The lack of gene expression after the boost is vein injection and a second dose of 5 × 10 9 p.f.u. of the same virus was applied on day 215 after the initial applinot surprising since the initial humoral response is very strong and leads to anti-Ad titers of up to 1/131 072 cation. Immunosuppression was started 1 day before virus application. Short-course suppression was applied (control group). A reduction of antibody formation by continuous immunosuppression to titers of about 1/4096 for 5 days after gene transfer. The immunosuppressants were diluted in PBS and applied in a volume of 200 l (DSG++ group) is remarkable but still high. Since 10-20% of antibodies have neutralizing qualities the remaining by daily intraperitoneal injection. The FK506 group received 1 mg/kg/day FK506, the cylosporin A group titers are sufficient to neutralize circulating viruses after the second application. The Western blot analysis of antireceived 20 mg/kg/day cyclosporin A, the DSG group received 10 mg/kg/day 15-DSG. After the initial 5-day gen patterns visualizes the reduction of antibody production, but shows at the same time that the proteins course, one group, referred to as the DSG++ group, received 15-DSG in a dose of 10 mg/kg twice weekly for leading to formation of neutralizing antibodies, especially 150 days. The control group received intraperitoneal was removed by centrifugation (12 000 g for 10 min) and protein content was determined by Bradford assay. ␤-injections of PBS only. 15-Deoxyspergualin was kindly provided from Behring-Werke (Marburg, Germany), Galactosidase activity was measured in 4 g total protein with ␤-galactosidase kit (Tropix, Bedford, MA, USA) FK506 from Fujisawa (Mü nchen, Germany) and cyclosporin A (Sandimmun) was purchased from Sandoz according to the manufacturer's instructions in a Berthold luminometer (Wildbad, Germany). Background (Nü rnberg, Germany).
For the investigation of ␤-galactosidase expression, expression in mouse liver ranged between 800-1500 relative light units (r.l.u.). four groups were set up, each group containing nine NMRI mice. On day 0, 1 × 10 10 p.f.u. Ad-␤-gal were Statistical analysis applied. Immunosuppression with 15-DSG (5 mg/ In addition to calculating mean values and standard kg/day) was started 1 day before virus application and deviation, the significance of observed differences continued for 5 days and in a second group for 21 days.
between groups or single mice was determined in the The third group received cyclosporin A (100 mg/kg/day) non-parametric Kolmogoroff-Smirnoff test (KS test). for 21 days. The control group received PBS injections Observed differences were stated to be significant when only. Three mice of each group were killed on days 6, 21 P was smaller than 0.05. and 42 after virus application and ␤-galactosidase expression in the liver was quantified as explained below.
